Additionally, FCN2 has been identified as an early predictor of myocardial infarction70 further underscoring its broader role in inflammatory and pain‐related conditions, including ME/CFS. This evidence concerns the gene FCN2 and myalgic encephalomeyelitis/chronic fatigue syndrome.